265 related articles for article (PubMed ID: 15833035)
1. Reaction kinetics of biotinylated organophosphorus toxicant, FP-biotin, with human acetylcholinesterase and human butyrylcholinesterase.
Schopfer LM; Voelker T; Bartels CF; Thompson CM; Lockridge O
Chem Res Toxicol; 2005 Apr; 18(4):747-54. PubMed ID: 15833035
[TBL] [Abstract][Full Text] [Related]
2. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry.
Peeples ES; Schopfer LM; Duysen EG; Spaulding R; Voelker T; Thompson CM; Lockridge O
Toxicol Sci; 2005 Feb; 83(2):303-12. PubMed ID: 15525694
[TBL] [Abstract][Full Text] [Related]
3. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
5. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
6. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
[TBL] [Abstract][Full Text] [Related]
7. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
8. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants.
Quistad GB; Klintenberg R; Casida JE
Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
12. Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activation.
Segall Y; Quistad GB; Sparks SE; Casida JE
Chem Res Toxicol; 2003 Mar; 16(3):350-6. PubMed ID: 12641435
[TBL] [Abstract][Full Text] [Related]
13. On-site analysis of acetylcholinesterase and butyrylcholinesterase activity with the ChE check mobile test kit-Determination of reference values and their relevance for diagnosis of exposure to organophosphorus compounds.
Worek F; Schilha M; Neumaier K; Aurbek N; Wille T; Thiermann H; Kehe K
Toxicol Lett; 2016 May; 249():22-8. PubMed ID: 27033775
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
[No Abstract] [Full Text] [Related]
15. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
16. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
17. Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds.
Aminoff D; Bochar DA; Fuller AA; Mapp AK; Showalter HD; Kirchhoff PD
Anal Biochem; 2009 Sep; 392(2):155-61. PubMed ID: 19497294
[TBL] [Abstract][Full Text] [Related]
18. Characteristic mass spectral fragments of the organophosphorus agent FP-biotin and FP-biotinylated peptides from trypsin and bovine albumin (Tyr410).
Schopfer LM; Champion MM; Tamblyn N; Thompson CM; Lockridge O
Anal Biochem; 2005 Oct; 345(1):122-32. PubMed ID: 16125664
[TBL] [Abstract][Full Text] [Related]
19. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
